Status:
COMPLETED
A Relative Bioavailability Study of 75mg Indomethacin Extended-Release Capsules
Lead Sponsor:
Sandoz
Conditions:
Inflammation
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
The purpose of this study is to demonstrate the bioequivalence of Indomethacin ER Capsules.
Eligibility Criteria
Inclusion
- No clinically significant abnormal findings on physical exam, medical history or clinical laboratory results on screening
Exclusion
- Positive test results for HIV or hepatitis B or C
- No allergies to indomethacin or related drugs
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2006
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00858195
Start Date
June 1 2006
End Date
July 1 2006
Last Update
March 29 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.